1 follower
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.
Industries
Headquarters
Stage
Employees
Links
Linda Marbán
View all
4 members
3 members
2 members
Coherus BioSciences
5 followers
BioMarin Pharmaceutical
20 followers
Adaptive Biotechnologies
11 followers
Eikon Therapeutics
Dragonfly Therapeutics
Discover companies